A Multicenter Phase II Trial to Evaluate Rechallenge With Platinum-based Chemotherapy (Carboplatin, Etoposide) for Progression During Tarlatamab Therapy in Relapsed Extensive Disease Small-cell Lung Cancer (SCLC)

NCT07699237 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
54
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Cologne